Igyxos Competitors and Similar CompaniesClear all
Versantis's competitors and similar companies include Roche and BioArctic.
 Versantis Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications. |  BioArctic BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 1896 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Zürich, CH HQ | Locations Stockholm , SE HQ | |
Employees | Employees 2 | Employees 103,249 | Employees 107 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) kr2b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods CHF13.1b (FY, 2025) | Cost of goods kr59.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit CHF50.5b (FY, 2025) | Gross profit kr1.9b (FY, 2025) |
Net income | Net income N/A | Net income CHF13.8b (FY, 2025) | Net income kr1b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 20.7m | Total funding raised $ 7.8b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View companyBioArctic
HQ
Stockholm , SE
Employees
107
BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.
View company